Read the latest positive news, breakthroughs, and inspiring stories about brain tumors, curated daily by BrightWire.
A 25-year-old swimmer with inoperable brain tumors just secured a meeting with the UK prime minister after making an emotional plea on national television. His tearful appeal for better brain cancer funding moved thousands and opened doors to the highest levels of government.
Researchers at Children's National have discovered that a rare brain tumor previously thought to be one disease is actually three distinct types, each requiring different treatment. This breakthrough could help doctors tailor therapies to save more young lives.
Korean researchers discovered why certain cancer treatments fail against glioblastoma and found an unexpected immune system player that could change everything. The breakthrough reveals that B cells, not just T cells, are essential for fighting aggressive brain tumors.
A groundbreaking treatment for children with deadly brain tumors has kept three young patients cancer-free for up to four years without additional treatment. The therapy uses a child's own cells to fight tumors that were once considered nearly impossible to treat.
A new radiation system in Augusta can zap brain tumors smaller than a pencil tip without a single incision. Patients skip surgery, anesthesia, and lengthy recovery times.
Brain tumor patients in Augusta, Georgia can now receive treatment without surgery, incisions, or even general anesthesia. The new Gamma Knife Esprit system is already helping patients heal faster with fewer side effects.
Only 12% of brain tumor patients in the UK join clinical trials—the lowest rate of all cancers. A new initiative called ACT-BT is changing that by connecting patients with potentially life-saving research opportunities.
Scientists used a genetically modified herpes virus to help immune cells attack glioblastoma, the deadliest brain tumor. Patients in the trial lived longer than expected, offering new hope after 20 years without treatment advances.
A national trial found that an existing cancer pill may slow aggressive brain tumors in patients who had run out of options. Nearly 60% of patients saw their tumors stop growing for at least six months.